Company profile: Anagram
1.1 - Company Overview
Company description
- Provider of clinical research organization (CRO) services.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Anagram
Lexitas
HQ: United States
Website
- Description: Provider of full-service ophthalmology CRO solutions for pharma and biotech, including end-to-end clinical operations, global site relationships and international regulatory expertise, medical and regulatory writing, medical monitoring, reading center image assessments, and data management, biostatistics, and statistical programming.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lexitas company profile →
Scorpius Biologics
HQ: United States
Website
- Description: Provider of integrated CDMO services for biologics, specializing in mammalian, microbial, and cell therapies. Offers biomanufacturing from pre-clinical to commercial, including analytical methods development, process development, cGMP manufacturing, product characterization, QC release testing, formulation development, and analytical testing, supported by a clinical-scale cGMP facility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scorpius Biologics company profile →
ProBioGen
HQ: Germany
Website
- Description: Provider of contract development and manufacturing and technology services for biopharmaceuticals, specializing in cell line engineering, scalable upstream and downstream process development, GMP manufacturing, and virus production. Offers development and manufacturing of therapeutic proteins and antibodies, custom stable production cell lines, and support for biosimilars and biobetters.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProBioGen company profile →
iCardiac
HQ: United States
Website
- Description: Provider of cardiac safety biomarkers and ECG-based markers for assessing the cardiac safety profile of drugs in development; offers Dynamic QTbtbsm, a suite of ECG-based cardiac safety markers, used in cardiac clinical trials by pharmaceutical, biotechnology, and medical device companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full iCardiac company profile →
NeuroTrax
HQ: United States
Website
- Description: Provider of BrainCare, a cloud-based brain wellness assessment platform offering tests across seven cognitive areas, graphical reports for clinicians to track baselines and progress, and personalized activity and brain training recommendations, plus a 30-minute Post COVID Testing Suite evaluating memory, executive function, attention, and information processing speed for post-COVID cognitive assessment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NeuroTrax company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Anagram
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Anagram
2.2 - Growth funds investing in similar companies to Anagram
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Anagram
4.2 - Public trading comparable groups for Anagram
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →